Aktis Oncology Q3 2026 net loss widens 93% to $29.9 million
Aktis Oncology Q3 2026 net loss widens 93% to $29.9 million Aktis Oncology’s third-quarter 2026
Aktis Oncology Q3 2026 net loss widens 93% to $29.9 million Aktis Oncology’s third-quarter 2026